×
About 1,908 results

ALLMedicine™ Chickenpox Center

Research & Reviews  311 results

Multicenter Evaluation of the Simplexa VZV Direct Assay for Detection of Varicella-Zost...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020333
Journal of Clinical Microbiology; Pancholi P, Relich RF et. al.

Mar 15th, 2022 - Varicella-zoster virus (VZV) is the etiologic agent of varicella (chickenpox) and herpes zoster (shingles) infections commonly involving skin, mucous membranes, and less frequently the central nervous system. Traditional methods for the laboratory...

Lipoid proteinosis: A systematic presentation of an unusual disease.
https://doi.org/10.1111/jocd.14861
Journal of Cosmetic Dermatology; Mofarrah R, Ghasemi M et. al.

Feb 18th, 2022 - Lipoid proteinosis (LP) or Hyalinosis Cutis et Mucosae or Urbach-Wiethe disease is a rare autosomal recessive genodermatosis characterized by an amorphous hyaline material deposition in the skin mucosa and viscera. The clinical symptoms of this di...

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
https://clinicaltrials.gov/ct2/show/NCT05084508

Feb 17th, 2022 - The purpose of this study is to assess immune response and safety of various potencies of an investigational chickenpox vaccine given to healthy children 12 to 15 months of age.

Paediatric erythema multiforme: not every bullous rash is chickenpox.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719153
BMJ Case Reports; Lança A, Bernardo M et. al.

Jan 1st, 2022 - Paediatric erythema multiforme: not every bullous rash is chickenpox.|2022|Lança A,Bernardo M,Pinto S,|complications,diagnosis,diagnosis,drug therapy,diagnosis,etiology,

Risk factors for some tropical diseases in an African country.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666074
BMC Public Health; Uzoka FE, Akwaowo C et. al.

Dec 14th, 2021 - Often, non-clinical risk factors could affect the predisposition of an individual to diseases. Understanding these factors and their impacts helps in disease prevention and control. This study identified risk factors for malaria, yellow fever, typ...

see more →

Drugs  315 results see all →

Clinicaltrials.gov  16 results

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
https://clinicaltrials.gov/ct2/show/NCT05084508

Feb 17th, 2022 - The purpose of this study is to assess immune response and safety of various potencies of an investigational chickenpox vaccine given to healthy children 12 to 15 months of age.

Study on Efficacy of Attenuated Zoster Vaccine, Live
https://clinicaltrials.gov/ct2/show/NCT04334577

Dec 8th, 2021 - Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes. Primary infection is manifested as varicella (chickenpox) , whereas reactivation of latent VZV results in a localized eruption known as herpes zoster. The i...

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
https://clinicaltrials.gov/ct2/show/NCT00001125

Nov 1st, 2021 - Varicella (chickenpox) results from primary infection with VZV. Varicella, a common and usually benign illness in normal children, is more severe in HIV-infected children and may result in other conditions such as HZ (shingles). HZ is due to react...

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age
https://clinicaltrials.gov/ct2/show/NCT03314103

Mar 30th, 2021 - Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes.Primary infection is manifested as varicella (chickenpox), whereas reactivation of latent VZV results in a localized eruption known as herpes zoster. More th...

Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines
https://clinicaltrials.gov/ct2/show/NCT04751695

Feb 12th, 2021 - Coronavirus-2019 (COVID-19) is a global epidemic that has serious consequences and affects the world with its rapid spread and high mortality rate. The number of people infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2) is r...

see more →

News  93 results

GOP Revives Anti-Vax, Pro-Ivermectin Measure in Kansas
https://www.medscape.com/viewarticle/970499

Mar 17th, 2022 - TOPEKA, Kan. (AP) — Conservative Republican lawmakers on Thursday revived a proposal to weaken Kansas' vaccination requirements for children enrolling in school and day care and to make it easier for people to get potentially dangerous treatments ...

ACIP Recommends Shingrix for Younger Immunocompromised Adults; Updates Pneumococcal Vaccine Guidance
https://www.medscape.com/viewarticle/961385

Oct 21st, 2021 - The US Centers for Disease Control and Prevention Advisory Committee of Immunization Practices (ACIP) has voted to recommend Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in immunodeficient or imm...

COVID Immunity Through Infection or Vaccination: Are They Equal?
https://www.medscape.com/viewarticle/960533

Oct 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Dr. Aaron Kheriaty, a University of California-Irvine psychiatry professor, felt he didn’t need to be vaccinated against covid because he’d fallen...

Hard-Won Gains at Risk as Delta Variant Spreads: WHO
https://www.medscape.com/viewarticle/955743

Aug 2nd, 2021 - GENEVA (Reuters) — The world is at risk of losing hard-won gains in fighting COVID-19, as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective against the disease, the World Health Organization said on Friday....

Shingrix OK'd for Immunocompromised Adults
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/93760

Jul 26th, 2021 - FDA expanded the approval of Shingrix, an adjuvanted recombinant zoster vaccine, for adults at increased risk of shingles due to immunosuppression, manufacturer GlaxoSmithKline (GSK) announced on Monday. The expanded indication is for adults ages ...

see more →

Patient Education  28 results see all →